Skip to content

ANTIBACTERIAL COATED ABSORBABLE SUTURE IS BETTER THAN REGULAR ABSORBABLE SUTURE FOR CLOSING CUTS MADE AT UMBILICUS FOR LAPAROSCOPIC SURGERIES

TRICLOSAN COATED POLYGLACTIN 910 VERSUS CONVENTIONAL POLYGLACTIN 910 FOR UMBILICAL PORT CLOSURE IN LAPAROSCOPIC SURGERIES : A RANDOMISED CONTROLLED TRIAL - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099737
Enrollment
80
Registered
2025-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: K352- Acute appendicitis with generalized peritonitis Health Condition 3: K353- Acute appendicitis with localizedperitonitis Health Condition 4: K409- Unilateral inguinal hernia, without obstruction or gangrene Health Condition 5: K800- Calculus of gallbladder with acutecholecystitis Health Condition 6: K802- Calculus of gallbladder without cholecystitis

Interventions

Intervention1: TRICLOSAN COATED POLYGLACTIN 910 SUTURE: Suture is used to close umbilical port site in laparoscopic surgery Control Intervention1: Conventional polyglactin 910 suture: Suture regularl

Sponsors

DR Satish Kumar Jena
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 to 65 yrs undergoing laparoscopic surgery ASA grade 1 and 2

Exclusion criteria

Exclusion criteria: Pre existing local or systemic infection Conversion to open surgery

Design outcomes

Primary

MeasureTime frame
Surgical site infection Port site painTimepoint: Surgical site infection using Southampton wound assessment scale Port site pain using Numeric pain rating scale

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDR Satish Kumar Jena

S, Nijalingappa Medical College And Hsk Hospital Bagalkot

shaileshemmi@gmail.com9113016341

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026